Operationalizing International Regulatory Standards in a Limited-Resource Setting during an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience

Abdul Karim Kabineh, Wendy Carr, Mahnaz Motevalli, Jennifer Legardy-Williams, Willietta Vincent, Barbara E. Mahon, Mohamed Samai

Research output: Contribution to journalArticle

Abstract

International regulatory standards ensure human subjects protection, data quality, and scientific integrity of clinical trials. Operationalizing regulatory standards during a large vaccine clinical trial - the Sierra Leone Trial to Introduce a Vaccine Against Ebola - in a resource-constrained setting during an epidemic required flexibility and creativity. We highlight areas that required special attention, such as developing standard operating procedures appropriate for the setting, obtaining space and supplies for the regulatory office, and creating a strategy to maintain both a dedicated central regulatory office and satellite regulatory sites for this trial with paper-based records.

Original languageEnglish (US)
Pages (from-to)S56-S59
JournalJournal of Infectious Diseases
Volume217
DOIs
StatePublished - May 18 2018

Keywords

  • Ebola
  • GCP
  • STRIVE
  • West Africa
  • clinical trials
  • regulatory
  • vaccines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Operationalizing International Regulatory Standards in a Limited-Resource Setting during an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience'. Together they form a unique fingerprint.

  • Cite this